Abstract
Henipavirus infection (NiV), a fatal disease transmitted by bats has caused human death and disease in India and Bangladesh. With an average case fatality rate of more than 70%, NiV has the potential to cause widespread outbreaks that can have a devastating impact on human health. Spillover of NiV from bats to humans is influenced by several factors mainly human behaviour and human interaction with bats. Climatic conditions and habitat destruction influence the shedding of the virus and the transmission of the disease to humans. Limited research has been conducted on the factors driving these spillover events. As the world has recently witnessed the devastating impact of the COVID-19 global pandemic, a forewarning of spillover events will enable the adoption of adequate measures to prevent and control future outbreaks. Our study maps the likely changing distribution of NiV reservoir Pteropus medius bat species using future climate and land-use change predictions. We use existing data to predict which districts within India and Bangladesh have increased risk of spillover of NiV in the future. We use Species Distribution Modelling to predict the likely change in the distribution of P. medius under different future scenarios and the concurrent increase in the risk of NiV spillover events. We focus on the influence of anthropogenic changes in different socioeconomic scenarios to predict future spillover events. We consider climate and social goals set by the International Panel on Climate Change (IPPC) to create accurate predictions of regions at risk of NiV spillovers. We find that the risk of NiV spillover events in India and Bangladesh will likely increase. More districts are predicted to be at risk of NiV spillovers under the high population growth and persistent environmental degradation scenario than under moderate population growth and medium challenges to achieve climate goals. This highlights the significance of population growth and climate change when considering disease outbreaks and public health. Our findings will enable the authorities in the predicted spillover regions to take public health measures to prevent and control NiV outbreaks.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced are available online at https://www.kaggle.com/varshabalachandra/risk-mapping-nipah-virus-spillover
https://www.kaggle.com/varshabalachandra/risk-mapping-nipah-virus-spillover